Education
About Us
Working with TipRanks
Follow Us
Amneal Pharma (AMRX)
NASDAQ:AMRX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.02B | $ 2.79B | $ 2.39B | $ 2.21B | $ 2.09B |
| Gross Profit | $ 1.11B | $ 1.02B | $ 863.87M | $ 791.46M | $ 768.97M |
| Operating Income | $ -5.24M | $ 249.33M | $ 204.37M | $ -94.93M | $ 152.72M |
| EBITDA | $ -5.24M | $ 439.77M | $ 500.78M | $ 440.21M | $ 401.10M |
| Net Income | $ 72.06M | $ -116.89M | $ -83.99M | $ -129.99M | $ 10.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 282.03M | $ 112.42M | $ 93.74M | $ 27.80M | $ 247.79M |
| Total Assets | $ 3.68B | $ 3.50B | $ 3.47B | $ 3.80B | $ 3.94B |
| Total Debt | $ 123.93M | $ 2.59B | $ 2.75B | $ 2.85B | $ 2.88B |
| Net Debt | $ -158.10M | $ 2.48B | $ 2.66B | $ 2.82B | $ 2.63B |
| Total Liabilities | $ 2.79B | $ 3.55B | $ 3.41B | $ 3.59B | $ 3.57B |
| Stockholders' Equity | $ 887.60M | $ -109.27M | $ 19.78M | $ 298.42M | $ 360.34M |
| Cash Flow | |||||
| Free Cash Flow | $ 269.93M | $ 220.11M | $ 276.39M | $ -25.50M | $ 194.09M |
| Operating Cash Flow | $ 339.99M | $ 295.10M | $ 345.58M | $ 65.10M | $ 241.82M |
| Investing Cash Flow | $ -112.26M | $ -63.00M | $ -69.19M | $ -174.31M | $ -194.18M |
| Financing Cash Flow | $ -31.53M | $ -211.79M | $ -212.57M | $ -106.62M | $ -138.12M |